Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News NLS Pharmaceutics AG NLSP

Healthcare Biotechnology
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:NLSP)

NLS Pharmaceutics CEO Issues Letter to Shareholders

PR Newswire 7 days ago

NLS Pharmaceutics Announces New Preclinical Data for AEX-2, Expanding the Therapeutic Potential of its Non-Sulfonamide Dual Orexin Receptor Agonist Platform

PR Newswire February 27, 2025

Kadimastem and iTolerance Successfully Complete Pre-IND Meeting with the FDA for its Type 1 Diabetes Treatment

PR Newswire February 25, 2025

NLS Pharmaceutics and Kadimastem Unveil Multi-Target Approach to Diabetes, Expanding Beyond GLP-1 Therapies

PR Newswire February 10, 2025

Kadimastem Shareholders Approved the Merger with NLS Pharmaceutics

PR Newswire January 31, 2025

NLS Pharmaceutics Announces the Submission of Three Research Abstracts to the 2025 ASCP Annual Meeting

PR Newswire January 30, 2025

NLS Pharmaceutics Announces the Launch of a Preclinical Program for Mazindol ER in the Treatment of Fentanyl Dependence

PR Newswire January 28, 2025

Kadimastem Calls for a Special General Meeting of Shareholders to Approve the Merger with NLS

PR Newswire January 16, 2025

NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce the Initial Closing of $500,000 of the Previously Announced $1 Million Fundraising by NLS Following its Extraordinary General Meeting at a Share Price of $3.10, Representing 48% Above the Market Share Price as of Jan 6, 2025

PR Newswire January 8, 2025
View More News ››

Opinion & Analysis (NDAQ:NLSP)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:NLSP)

Using technical analysis for this stock.

It looks like it is going to be taking off today because of the big announcement s this morning,so that you fellas should be getting on...
coolfooldumbguy - February 10, 2025

Buy buddy buy because it's taking off this morning.

This stock was doing a big merger and it should be going up after completing the process.
coolfooldumbguy - January 31, 2025

Watching and waiting to see

What will be happening with this stock today.
coolfooldumbguy - January 8, 2025

NLS Pharmaceutics and Kadimastem Announce the Submission of

News; $NLSP NLS Pharmaceutics and Kadimastem Announce the Submission of a Request by Kadimastem and iTolerance, Inc. for an FDA Pre-IND...
whytestocks - December 19, 2024

NLSP...N.L.O.D

$0.26 now
Iseneschal - July 29, 2024

NLSP....has to get past $0.315 or it toast

JMHO....currently at $0.28
Iseneschal - July 29, 2024
View more Bullboard ››

Hypha Labs Inc.

Hypha Labs Inc.

Hypha Labs, Inc.is engaged in the research, development and commercialization of a revolutionary mushroom accelerator, the ...
View More »